DOXERCALCIFEROL

Generic: DOXERCALCIFEROL

Meitheal Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
DOXERCALCIFEROLActive Substance
2020-02-07Original Approval

DOXERCALCIFEROL is FDA application ANDA211670, sponsored by MEITHEAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DYSPNOEA
13 reports
2
ACUTE KIDNEY INJURY
12 reports
3
FATIGUE
12 reports
4
RENAL FAILURE
12 reports
5
END STAGE RENAL DISEASE
11 reports
6
VOMITING
11 reports
7
CHRONIC KIDNEY DISEASE
10 reports
8
DRUG HYPERSENSITIVITY
10 reports
9
NAUSEA
9 reports
10
PAIN
9 reports